DXCM - DexCom, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

DexCom, Inc.

6340 Sequence Drive
San Diego, CA 92121
United States
858-200-0200
http://www.dexcom.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees2,290

Key Executives

NameTitlePayExercisedYear Born
Mr. Terrance H. GreggExec. ChairmanN/AN/A1949
Mr. Kevin R. SayerCEO, Pres & Director1.08M1.64M1958
Mr. Quentin S. BlackfordExec. VP & CFON/AN/A1979
Mr. Steven R. PacelliExec. VP of Strategy & Corp. Devel.613.34k3171972
Mr. Andrew K. BaloExec. VP of Clinical Affairs, Regulatory Strategies & Global AccessN/AN/A1948
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Corporate Governance

DexCom, Inc.’s ISS Governance QualityScore as of June 1, 2018 is 2. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 3; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.